• Explore /
  • Poster
  • / Androgen deprivation therapy and overall survival for Gleason 8 versus Gleason 9-10 prostate cancer.

Androgen deprivation therapy and overall survival for Gleason 8 versus Gleason 9-10 prostate cancer.

Abstract Poster

Authors

null

David Dewei Yang

Harvard Medical School, Boston, MA

David Dewei Yang , Brandon Arvin Virgil Mahal , Vinayak Muralidhar , Neil E. Martin , Peter F. Orio , Kent William Mouw , Martin T. King , Toni K. Choueiri , Quoc-Dien Trinh , Karen E. Hoffman , Daniel Eidelberg Spratt , Felix Y Feng , Paul L. Nguyen

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer,Prostate Cancer

Sub Track

Prostate Cancer - Localized Disease

Citation

J Clin Oncol 36, 2018 (suppl 6S; abstr 23)

DOI

10.1200/JCO.2018.36.6_suppl.23

Abstract #

23

Poster Bd #

B7

Abstract Disclosures

Similar Posters

Poster

2018 Genitourinary Cancers Symposium

Primary resistance in docetaxel and androgen deprivation therapy in metastatic castrate sensitive prostate cancer patients.

Primary resistance in docetaxel and androgen deprivation therapy in metastatic castrate sensitive prostate cancer patients.

First Author: Athanasios Pouptsis

First Author: Guangxi Sun

First Author: Joelle Helou

First Author: Earle F Burgess